Clinical trial
A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to…
NCT00238654 · Teva Neuroscience, Inc., Industry · Completed
Key facts
| NCT number | NCT00238654 |
|---|---|
| Title | A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy |
| Official title | A Multicenter, Open-Label, Two-Arm Prospective Study to Evaluate the Impact of Patient Readiness to Self-Inject on Outcomes When Using the Copaxone® Prefilled Syringes [The "READY" Trial] |
| Lead sponsor | Teva Neuroscience, Inc., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Enrollment | 257 |
| Start date | May 1, 2003 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Oct 13, 2005 |
| Last update posted | Apr 12, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: